Zhitong Finance App News, Mingde Biotech (002932.SZ) issued an announcement. The company and Lanfan Medical Co., Ltd. (hereinafter referred to as the “counterparty” or “Blue Sail Medical”) signed a “Share Acquisition Intent Agreement”. The two parties reached a framework agreement on the company's transaction to acquire 100% of the shares of Wuhan Bicyle Rescue Products Co., Ltd. (hereinafter referred to as the “target company”) in cash, and clarified matters such as the subsequent acquisition work arrangements and the signing of a formal acquisition agreement between the two parties. According to preliminary estimates, the transaction is expected to constitute a major asset restructuring as stipulated in the “Administrative Measures on Major Asset Restructuring of Listed Companies”.

Zhitong Finance App News, Mingde Biotech (002932.SZ) issued an announcement. The company and Lanfan Medical Co., Ltd. (hereinafter referred to as the “counterparty” or “Blue Sail Medical”) signed a “Share Acquisition Intent Agreement”. The two parties reached a framework agreement on the company's transaction to acquire 100% of the shares of Wuhan Bicyle Rescue Products Co., Ltd. (hereinafter referred to as the “target company”) in cash, and clarified matters such as the subsequent acquisition work arrangements and the signing of a formal acquisition agreement between the two parties. According to preliminary estimates, the transaction is expected to constitute a major asset restructuring as stipulated in the “Administrative Measures on Major Asset Restructuring of Listed Companies”.